Detalhe da pesquisa
1.
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence.
Pediatr Blood Cancer
; 68(7): e29047, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860611
2.
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study.
Lancet Oncol
; 21(1): 134-144, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31780255
3.
Prevalence of Symptomatic and Asymptomatic Thrombosis in Pediatric Oncology Patients With Tunneled Central Venous Catheters.
Pediatr Blood Cancer
; 63(8): 1438-44, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27128820
4.
Changes in body mass index in long-term childhood cancer survivors.
Cancer
; 121(23): 4197-204, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26287726
5.
Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer - An ACCELERATE Multistakeholder Consensus.
Clin Pharmacol Ther
; 115(1): 36-41, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37885401
6.
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
J Clin Oncol
; 42(10): 1135-1145, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190578
7.
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy.
Cancer Cell
; 42(2): 283-300.e8, 2024 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181797
8.
Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours.
Eur J Cancer
; 170: 196-208, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35671543
9.
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.
Eur J Cancer
; 162: 107-117, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963094
10.
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
Eur J Cancer
; 166: 145-164, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290915
11.
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Neuro Oncol
; 24(10): 1776-1789, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395680
12.
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Eur J Cancer
; 157: 198-213, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536944
13.
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers.
Eur J Cancer
; 130: 168-181, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32224415
14.
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy.
Eur J Cancer
; 130: 72-80, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32179448
15.
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
Eur J Cancer
; 136: 52-68, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653773
16.
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Eur J Cancer
; 127: 52-66, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31986450
17.
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.
Eur J Cancer
; 110: 74-85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772656
18.
Declining free thyroxine levels over time in irradiated childhood brain tumor survivors.
Endocr Connect
; 7(12): 1322-1332, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30400062
19.
Risk and associated risk factors of hospitalization for specific health problems over time in childhood cancer survivors: a medical record linkage study.
Cancer Med
; 6(5): 1123-1134, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28378525
20.
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.
Expert Opin Drug Discov
; 12(8): 801-811, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28604107